These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39059480)

  • 1. Comparison of clot waveform analysis with or without adjustment between prothrombin time and activated partial thromboplastin time assays to assess in vitro effects of direct oral anticoagulants.
    Wakui M; Fujimori Y; Ozaki Y; Oka S; Ziparo M; Osada E; Kondo Y; Nakagawa T; Nakamura S; Matsushita H
    Clin Chim Acta; 2024 Aug; 562():119887. PubMed ID: 39059480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
    Testa S; Legnani C; Tripodi A; Paoletti O; Pengo V; Abbate R; Bassi L; Carraro P; Cini M; Paniccia R; Poli D; Palareti G
    J Thromb Haemost; 2016 Nov; 14(11):2194-2201. PubMed ID: 27566988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis.
    Wakui M; Fujimori Y; Katagiri H; Nakamura S; Kondo Y; Kuroda Y; Nakagawa T; Shimizu N; Murata M
    J Clin Pathol; 2019 Mar; 72(3):244-250. PubMed ID: 30518630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab.
    Nogami K; Matsumoto T; Tabuchi Y; Soeda T; Arai N; Kitazawa T; Shima M
    J Thromb Haemost; 2018 Jun; 16(6):1078-1088. PubMed ID: 29645406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls.
    Evrard J; Siriez R; Bouvy C; Favresse J; Yildiz H; Hainaut P; Mullier F; Dogné JM; Douxfils J
    Res Pract Thromb Haemost; 2022 Oct; 6(7):e12804. PubMed ID: 36349263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of antithrombin-dependent anticoagulants through clot waveform analysis to potentially distinguish them from antithrombin-independent inhibitors targeting activated coagulation factors.
    Wakui M; Fujimori Y; Nakamura S; Oka S; Ozaki Y; Kondo Y; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2021 Apr; 74(4):251-256. PubMed ID: 32796051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A; Chantarangkul V; Legnani C; Testa S; Tosetto A
    J Thromb Haemost; 2018 Mar; 16(3):565-570. PubMed ID: 29322630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Status Using Clot Wave Analysis in Patients With Prolonged Immobilization.
    Iberahim S; Muhamat Yusoff R; Mohd Noor NH; Hassan R; Ramli NN; Bahar R; Zulkafli Z; Wan Ab Rahman WS; Ab Ghani AS
    Cureus; 2024 Jan; 16(1):e51483. PubMed ID: 38304638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot Waveform Analysis for Monitoring Hemostasis.
    Nogami K
    Semin Thromb Hemost; 2023 Sep; 49(6):592-599. PubMed ID: 36174610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon.
    Frans G; Meeus P; Bailleul E
    J Thromb Haemost; 2019 Aug; 17(8):1354-1362. PubMed ID: 31102433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin.
    Cheong MA; Tan CW; Wong WH; Kong MC; See E; Yeang SH; Koh SK; Shim YT; Lee LH; Ng HJ
    Hematology; 2022 Dec; 27(1):337-342. PubMed ID: 35255239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of clot-fibrinolysis waveform analysis to assessment of in vitro effects of direct oral anticoagulants on fibrinolysis.
    Oka S; Wakui M; Fujimori Y; Kuroda Y; Nakamura S; Kondo Y; Nakagawa T; Katagiri H; Murata M
    Int J Lab Hematol; 2020 Jun; 42(3):292-298. PubMed ID: 32078255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents.
    Dale BJ; Ginsberg JS; Johnston M; Hirsh J; Weitz JI; Eikelboom JW
    J Thromb Haemost; 2014 Nov; 12(11):1810-5. PubMed ID: 25196577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot Waveform Analysis for Hemostatic Abnormalities.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Shimaoka M
    Ann Lab Med; 2023 Nov; 43(6):531-538. PubMed ID: 37387486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.